{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:54:58Z","timestamp":1753440898448,"version":"3.40.5"},"reference-count":81,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jfma.2024.02.010","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T14:59:45Z","timestamp":1709132385000},"page":"1218-1227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Taiwan ocular inflammation society consensus recommendations for the management of juvenile idiopathic arthritis-associated uveitis"],"prefix":"10.1016","volume":"123","author":[{"given":"Wei-Dar","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hsiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9528-2252","authenticated-orcid":false,"given":"Po-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0309-675X","authenticated-orcid":false,"given":"Liang-Shiou","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6346-8485","authenticated-orcid":false,"given":"De-Kuang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shwu-Jiuan","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0791-8303","authenticated-orcid":false,"given":"Wei-Yu","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8751-3148","authenticated-orcid":false,"given":"Yo-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8049-456X","authenticated-orcid":false,"given":"Wei-Chun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh-Fu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8431-2647","authenticated-orcid":false,"given":"Jerry","family":"Chien-Chieh Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-2316","authenticated-orcid":false,"given":"Tzu-En","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Yi","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning-Yi","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2744-3234","authenticated-orcid":false,"given":"Yih-Shiou","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ICU.0b013e32833eab83","article-title":"Juvenile idiopathic arthritis-associated uveitis","volume":"21","author":"Qian","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"issue":"7","key":"10.1016\/j.jfma.2024.02.010_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1542\/pir.33.7.303","article-title":"Juvenile idiopathic arthritis","volume":"33","author":"Espinosa","year":"2012","journal-title":"Pediatr Rev"},{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2015.20","article-title":"Uveitis associated with juvenile idiopathic arthritis","volume":"11","author":"Sen","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.jfma.2024.02.010_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070625","article-title":"Juvenile idiopathic arthritis-associated uveitis: a nationwide population-based study in Taiwan","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jfma.2024.02.010_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jmii.2012.03.006","article-title":"Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: a community-based cohort study in Taiwan","volume":"46","author":"Shen","year":"2013","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12969-019-0363-0","article-title":"Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease","volume":"17","author":"Shih","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/aos.13877","article-title":"Uveitis causes according to immune status of patients","volume":"97","author":"Rothova","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.jfma.2024.02.010_bib8","first-page":"1107","article-title":"Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative","volume":"77","author":"Constantin","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/acr.23871","article-title":"American College of rheumatology\/arthritis foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis","volume":"71","author":"Angeles-Han","year":"2019","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.jfma.2024.02.010_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/acr.23610","article-title":"Childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis","volume":"71","author":"Angeles-Han","year":"2019","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/ceo.13856","article-title":"Recommendations for the management of childhood juvenile idiopathic arthritis-type chronic anterior uveitis","volume":"49","author":"Smith","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bjophthalmol-2018-313789","article-title":"Areas of agreement in the management of childhood non-infectious chronic anterior uveitis in the UK","volume":"104","author":"Solebo","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1067\/mpa.2002.129045","article-title":"Time of onset of uveitis in children with juvenile rheumatoid arthritis","volume":"6","author":"Kodsi","year":"2002","journal-title":"J AAPOS"},{"issue":"7","key":"10.1016\/j.jfma.2024.02.010_bib14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/rheumatology\/kep459","article-title":"Developing standards of care for patients with juvenile idiopathic arthritis","volume":"49","author":"Wallace","year":"2010","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jfma.2024.02.010_bib15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ophtha.2020.08.024","article-title":"Uveitis in juvenile idiopathic arthritis: 18-year outcome in the population-based Nordic cohort study","volume":"128","author":"Rypdal","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfma.2024.02.010_bib16","series-title":"Textbook of pediatric rheumatology","first-page":"272","article-title":"Enthesitis-related arthritis (juvenile ankylosing spondylitis)","author":"Petty","year":"2011"},{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib17","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","article-title":"Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines","volume":"46","author":"Heiligenhaus","year":"2007","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jfma.2024.02.010_bib18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jmii.2022.02.003","article-title":"Step-wise diagnostic approach for patients with uveitis - experts consensus in Taiwan","volume":"55","author":"Hwang","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103086","article-title":"Prevalence and titres of antinuclear antibodies in juvenile idiopathic arthritis: a systematic review and meta-analysis","volume":"21","author":"Storwick","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.jfma.2024.02.010_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/09273948.2013.841495","article-title":"Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis","volume":"22","author":"Pelegrin","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"10.1016\/j.jfma.2024.02.010_bib21","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/art.40544","article-title":"Risk factors and biomarkers for the occurrence of uveitis in juvenile idiopathic arthritis: data from the inception cohort of newly diagnosed patients with juvenile idiopathic arthritis study","volume":"70","author":"Tappeiner","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib22","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1093\/rheumatology\/keaa733","article-title":"A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis","volume":"60","author":"van Straalen","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12969-017-0195-8","article-title":"Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study","volume":"15","author":"Nordal","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12969-019-0318-5","article-title":"Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ)","volume":"17","author":"Yasumura","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"issue":"12","key":"10.1016\/j.jfma.2024.02.010_bib25","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3899\/jrheum.130302","article-title":"Risk markers of juvenile idiopathic arthritis-associated uveitis in the childhood arthritis and rheumatology research alliance (CARRA) registry","volume":"40","author":"Angeles-Han","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jfma.2024.02.010_bib26","article-title":"The role of gender in juvenile idiopathic arthritis-associated uveitis","volume":"2014","author":"Moradi","year":"2014","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13075-020-02166-3","article-title":"Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany","volume":"22","author":"Heiligenhaus","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.jfma.2024.02.010_bib28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.survophthal.2021.06.006","article-title":"Pediatric uveitis: a comprehensive review","volume":"67","author":"Maleki","year":"2022","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.jfma.2024.02.010_bib29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jfma.2024.02.010_bib30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","article-title":"Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Heiligenhaus","year":"2012","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.jfma.2024.02.010_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0039-6257(03)00084-5","article-title":"Recent advances in uveitis of juvenile idiopathic arthritis","volume":"48","author":"Kotaniemi","year":"2003","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"10.1016\/j.jfma.2024.02.010_bib32","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3899\/jrheum.081318","article-title":"Biomarkers of chronic uveitis in juvenile idiopathic arthritis: predictive value of antihistone antibodies and antinuclear antibodies","volume":"36","author":"Nordal","year":"2009","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.jfma.2024.02.010_bib33","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1167\/iovs.12-10865","article-title":"Intraocular biomarker identification in uveitis associated with juvenile idiopathic arthritis","volume":"54","author":"Kalinina Ayuso","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib34","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1167\/iovs.13-13444","article-title":"Correlation between disease severity and presence of ocular autoantibodies in juvenile idiopathic arthritis-associated uveitis","volume":"55","author":"Walscheid","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.jfma.2024.02.010_bib35","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ophtha.2009.12.003","article-title":"Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids","volume":"117","author":"Thorne","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","article-title":"Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study","volume":"120","author":"Gregory","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jfma.2024.02.010_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/092739490500192","article-title":"A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation","volume":"12","author":"Gaudio","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.jfma.2024.02.010_bib38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40265-020-01314-y","article-title":"Uveitis therapy: the corticosteroid options","volume":"80","author":"Valdes","year":"2020","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semarthrit.2018.11.004","article-title":"Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis","volume":"49","author":"Heiligenhaus","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0301-4738.58468","article-title":"Current approach in diagnosis and management of anterior uveitis","volume":"58","author":"Agrawal","year":"2010","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12969-016-0088-2","article-title":"Juvenile idiopathic arthritis-associated uveitis","volume":"14","author":"Clarke","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.jfma.2024.02.010_bib42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajo.2007.06.030","article-title":"Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis","volume":"144","author":"Sijssens","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib43","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","article-title":"Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients","volume":"108","author":"Samson","year":"2001","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jfma.2024.02.010_bib44","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/rheumatology\/kes186","article-title":"Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach","volume":"52","author":"Simonini","year":"2013","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jfma.2024.02.010_bib45","first-page":"362","article-title":"Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Wierk","year":"2005","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12969-018-0255-8","article-title":"Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting","volume":"16","author":"Ferrara","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"10.1016\/j.jfma.2024.02.010_bib47","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/112067210701700509","article-title":"Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication","volume":"17","author":"Heiligenhaus","year":"2007","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jfma.2024.02.010_bib48","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","article-title":"Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Heiligenhaus","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jfma.2024.02.010_bib49","first-page":"1","article-title":"Epidemiology, treatment, and outcomes of juvenile idiopathic arthritis-associated uveitis: a multi-institutional study in Taiwan","author":"Wu","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"issue":"17","key":"10.1016\/j.jfma.2024.02.010_bib50","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","article-title":"Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis","volume":"376","author":"Ramanan","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jfma.2024.02.010_bib51","first-page":"1146","article-title":"Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey","volume":"34","author":"Foeldvari","year":"2007","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.jfma.2024.02.010_bib52","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1089\/jop.2020.0081","article-title":"Anti-tumor necrosis factor treatment in the management of pediatric noninfectious uveitis: infliximab versus adalimumab","volume":"37","author":"Ucan Gunduz","year":"2021","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"8","key":"10.1016\/j.jfma.2024.02.010_bib53","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3899\/jrheum.171006","article-title":"Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis","volume":"45","author":"Cecchin","year":"2018","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jfma.2024.02.010_bib54","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40744-021-00296-x","article-title":"Efficacy and safety of anti-TNFalpha therapy for uveitis associated with juvenile idiopathic arthritis: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2021","journal-title":"Rheumatol Ther"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib55","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12969-021-00630-1","article-title":"Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab","volume":"19","author":"Lanz","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib56","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/rheumatology\/key406","article-title":"Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study","volume":"58","author":"Heiligenhaus","year":"2019","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.20904","article-title":"A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis","volume":"53","author":"Smith","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jfma.2024.02.010_bib58","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keh658","article-title":"Etanercept and uveitis in patients with juvenile idiopathic arthritis","volume":"44","author":"Schmeling","year":"2005","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.jfma.2024.02.010_bib59","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/09273948.2019.1605453","article-title":"Effect of janus kinase inhibitor treatment on anterior uveitis and associated macular edema in an adult patient with juvenile idiopathic arthritis","volume":"27","author":"Bauermann","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.jfma.2024.02.010_bib60","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/S2665-9913(20)30008-4","article-title":"Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial","volume":"2","author":"Ramanan","year":"2020","journal-title":"The Lancet Rheumatology"},{"issue":"3","key":"10.1016\/j.jfma.2024.02.010_bib61","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/art.39940","article-title":"Anti-Interleukin-6 receptor tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-tumor necrosis factor therapy: a multicenter study of twenty-five patients","volume":"69","author":"Calvo-R\u00edo","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.jfma.2024.02.010_bib62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bjo.2009.173542","article-title":"Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis","volume":"95","author":"Goebel","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jfma.2024.02.010_bib63","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10067-019-04875-w","article-title":"JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis","volume":"39","author":"Miserocchi","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib64","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acr.20115","article-title":"Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis","volume":"62","author":"Zulian","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"8","key":"10.1016\/j.jfma.2024.02.010_bib65","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/rheumatology\/ker107","article-title":"Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab)","volume":"50","author":"Heiligenhaus","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.jfma.2024.02.010_bib66","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajo.2016.09.018","article-title":"Ocular hypotony in patients with juvenile idiopathic arthritis-associated uveitis","volume":"173","author":"B\u00f6hm","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jfma.2024.02.010_bib67","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/09273948.2016.1142573","article-title":"Occurrence of and risk factors for ocular hypertension and secondary glaucoma in juvenile idiopathic arthritis-associated uveitis","volume":"25","author":"Stroh","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.jfma.2024.02.010_bib68","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","article-title":"Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss","volume":"143","author":"Thorne","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jfma.2024.02.010_bib69","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ajo.2006.11.025","article-title":"Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis","volume":"143","author":"Woreta","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jfma.2024.02.010_bib70","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jcjo.2017.01.011","article-title":"Adult patients with uveitis associated with juvenile idiopathic arthritis: a retrospective review","volume":"52","author":"Kolomeyer","year":"2017","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09273940590909220","article-title":"Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults","volume":"13","author":"Ozdal","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib72","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/ard.2004.026955","article-title":"Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients","volume":"64","author":"Kotaniemi","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.jfma.2024.02.010_bib73","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/rheumatology\/ket256","article-title":"Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies","volume":"52","author":"Vidqvist","year":"2013","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jfma.2024.02.010_bib74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajo.2010.08.021","article-title":"Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis","volume":"151","author":"Kalinina Ayuso","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfma.2024.02.010_bib75","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ajo.2019.06.007","article-title":"Adalimumab in juvenile idiopathic arthritis-associated uveitis: 5-year follow-up of the bristol participants of the SYCAMORE trial","volume":"207","author":"Horton","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib76","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2015.04.016","article-title":"Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors","volume":"160","author":"Lerman","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jfma.2024.02.010_bib77","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00417-016-3497-5","article-title":"Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis","volume":"255","author":"Breitbach","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.jfma.2024.02.010_bib78","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3899\/jrheum.161336","article-title":"Predictors of relapse after discontinuing systemic treatment in childhood autoimmune chronic uveitis","volume":"44","author":"Simonini","year":"2017","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.jfma.2024.02.010_bib79","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/09273948.2018.1424341","article-title":"Relapse of juvenile idiopathic arthritis-associated uveitis after discontinuation of immunomodulatory therapy","volume":"27","author":"Acharya","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.jfma.2024.02.010_bib80","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","article-title":"Development and validation of a composite disease activity score for juvenile idiopathic arthritis","volume":"61","author":"Consolaro","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jfma.2024.02.010_bib81","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/acr.24963","article-title":"New and updated recommendations for the treatment of juvenile idiopathic arthritis-associated uveitis and idiopathic chronic anterior uveitis","volume":"75","author":"Foeldvari","year":"2023","journal-title":"Arthritis Care Res"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664624001104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664624001104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T16:05:35Z","timestamp":1732637135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664624001104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":81,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0929664624001104"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2024.02.010","relation":{},"ISSN":["0929-6646"],"issn-type":[{"type":"print","value":"0929-6646"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Taiwan ocular inflammation society consensus recommendations for the management of juvenile idiopathic arthritis-associated uveitis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2024.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}